• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Can a Blood Test Diagnose Depression?

Can a Blood Test Diagnose Depression?

May 1, 2012
Glen Spielmans, PhD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Glen Spielmans, PhD Associate professor of psychology, Metropolitan State University, St. Paul, MN Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Subject:
Depression

Short Description:
Can a Blood Test Diagnose Depression?

Background:

Psychiatrists have long wondered whether someday we might have an objective way to diagnose depression, in much the same way an internist orders a blood test or X-ray. A recent article suggests that just such a test might be on the horizon. Is it the real deal?

Investigators obtained blood samples from depressed and non-depressed patients. They measured levels of nine “biomarker” proteins and performed a calculation to get an “MDDScore.” The details of the calculation are undisclosed, proprietary information, but the end result is straightforward: a number on a scale of 0 to 100, where anything over 50 suggests depression. In a pilot study of 36 depressed and 43 non-depressed patients, the average MDDScores were 85.5 for depressed patients and 32.9 for others. A follow-up replication study of 34 depressed patients found an average score of 81. There were a few false negatives and positives, but the sensitivity and specificity were high, at about 91% and 81%, respectively.

Investigators selected the biomarkers from an initial set of 110 candidates because they helped to distinguish depressed people from non-depressed people. Markers included metabolic, inflammatory, and neurotrophic proteins, among others. Interestingly, in the published study, only four markers were consistently (and significantly) different between the two populations. Whether these four were weighted more heavily in the MDDScore calculation is unknown.

While the results are certainly impressive, they should be taken with a grain of salt. For one thing, there’s no known reason why these nine (or in the paper, only four) proteins should be elevated in depression, or whether they normalize with treatment. Also, subjects were all relatively healthy, not taking NSAIDs or antidepressants, and had no other psychiatric complaints or “unstable medical disorders.” The authors also did not control for demographic factors.

Furthermore, the authors point out that the test cannot differentiate bipolar from unipolar depression (although they’re investigating this) or, for that matter, any other psychiatric condition; it cannot be used to predict vulnerability to depression in someone without clinical symptoms; and it does not reflect the severity or prognosis of a patient’s depression. Nevertheless, the article’s sponsor, Ridge Diagnostics, has already begun marketing the test (at $745 a pop) directly to clinicians and patients (Papakostas GI et al, Molecular Psychiatry 2011;online ahead of print).

TCPR's Take:
There may indeed be some biochemical differences between some depressed patients and non-depressed individuals, and this study may give us some early hints. But the question is certainly still in the research stage. Individuals with depressive symptoms but a negative test still deserve treatment, while a positive MDDScore in the absence of subjective complaints presents an entirely different dilemma. Until the science is made a bit more transparent and more data are obtained—preferably with patients that resemble those we see in practice, and with more controls—we recommend that you save yourself the $745 and steer clear of this test.
General Psychiatry
KEYWORDS antidepressants
    Ccpr octnovdec2020 qa1 headshot spielmans 150x150
    Glen Spielmans, PhD

    L-Methylfolate May Offer Modest Boost to Antidepressants

    More from this author
    www.thecarlatreport.com
    Issue Date: May 1, 2012
    SUBSCRIBE NOW
    Table Of Contents
    Predicting Antidepressant Response
    Can a Blood Test Diagnose Depression?
    Is It Possible that Antidepressants Really Don’t Work?
    Future Developments in Antidepressant Therapy
    DOWNLOAD NOW
    Featured Book
    • MFB6eCover.jpg

      Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

      Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
      READ MORE
    Featured Video
    • therapist_canstockphoto9201097.jpg
      General Psychiatry

      Using SAMe In Clinical Practice with Garrett Rossi, MD

      Read More
    Featured Podcast
    • canstockphoto22709844.jpg
      General Psychiatry

      Psychopharm Commandment #10: Don’t Fear these Meds

      Surprising health benefits of our riskiest meds: Lithium, quetiapine, and clozapine.

      Listen now
    Recommended
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report

    Contact

    info@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.